Gastrointestinal Cancer News

Poor oral health correlated with an increased risk for hepatobiliary cancers, including hepatocellular carcinoma, according to an analysis of data from the UK Biobank cohort.

SAN DIEGO — Presenting individuals with more choices did not increase the likelihood of participation in colorectal cancer screening programs, according to study results presented at Digestive Disease Week.

Readministration of anti-PD-1 or anti-PD-L1 inhibitors after mild or severe immune-related adverse events appeared to carry acceptable risks vs. rewards, according to study results published in JAMA Oncology.

Chronic hepatitis B virus infection is associated with the risk for nonliver cancers, especially digestive system cancers, according to findings from a population-based cohort study published in JAMA Network Open.

Tumor mutational burden appeared to independently predict which patients with microsatellite instability-high metastatic colorectal cancer would respond to immune checkpoint inhibitors, according to study results published in Annals of Oncology.

Men who eat at least two servings of yogurt a week could have a reduced risk for developing precancerous growths in the bowel, according to data published in Gut.

CHICAGO — Yann Orsi, head of global therapeutic area oncology at Servier Pharmaceuticals, spoke with HemOnc Today about its philosophy and research efforts.

CHICAGO — One-third of a small cohort of patients with advanced gastric or pancreatic adenocarcinoma achieved objective responses to treatment with a novel claudin 18.2-specific chimeric antigen receptor T-cell therapy, according to results of a single-arm, phase 1 trial presented at ASCO Annual Meeting.

In this guest commentary, Gerald Fletcher, MD, MBA, from Harlem Hospital Center, discusses the data he presented during Digestive Disease Week 2019. His study, titled “Disparities in colorectal cancer screening: The effect of ACA Medicaid expansion on minorities and low-income populations,” highlights areas of need within these populations regarding CRC screening.

CHICAGO — HemOnc Today Next Gen Innovator Michael S. Lee, MD, assistant professor of medicine at the University of North Carolina, Chapel Hill, and oncologist at the Lineberger Comprehensive Cancer Center, discusses two “key” abstracts in gastrointestinal cancer that were presented at the ASCO Annual Meeting.